EYEN•benzinga•
Eyenovia Says Disappointed That DRC Determined That Chaperone Study Does Not Appear To Be Meeting Its Primary Efficacy Endpoint; To Discontinue Study, Review Full Data Set, And Evaluate Next Steps For The Program
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 15, 2024 by benzinga